Research ExplorerPublicationsSerum enterolactone and prognosis of postmenopausal breast c...

Serum enterolactone and prognosis of postmenopausal breast cancer.

Standard

Serum enterolactone and prognosis of postmenopausal breast cancer. / Buck, Katharina; Vrieling, Alina; Zaineddin, Aida Karina; Becker, Susen; Hüsing, Anika; Kaaks, Rudolf; Linseisen, Jakob; Flesch-Janys, Dieter; Chang-Claude, Jenny.

In: J CLIN ONCOL, Vol. 29, No. 28, 28, 2011, p. 3730-3738.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Buck, K, Vrieling, A, Zaineddin, AK, Becker, S, Hüsing, A, Kaaks, R, Linseisen, J, Flesch-Janys, D & Chang-Claude, J 2011, 'Serum enterolactone and prognosis of postmenopausal breast cancer.', J CLIN ONCOL, vol. 29, no. 28, 28, pp. 3730-3738. <http://www.ncbi.nlm.nih.gov/pubmed/21900115?dopt=Citation>

APA

Buck, K., Vrieling, A., Zaineddin, A. K., Becker, S., Hüsing, A., Kaaks, R., Linseisen, J., Flesch-Janys, D., & Chang-Claude, J. (2011). Serum enterolactone and prognosis of postmenopausal breast cancer. J CLIN ONCOL, 29(28), 3730-3738. [28]. http://www.ncbi.nlm.nih.gov/pubmed/21900115?dopt=Citation

Vancouver

Buck K, Vrieling A, Zaineddin AK, Becker S, Hüsing A, Kaaks R et al. Serum enterolactone and prognosis of postmenopausal breast cancer. J CLIN ONCOL. 2011;29(28):3730-3738. 28.

Bibtex

@article{c95c5067848242519d2c9c6c0b09b7c5,
title = "Serum enterolactone and prognosis of postmenopausal breast cancer.",
abstract = "Lignans--plant-derived compounds with estrogen-dependent and -independent anticarcinogenic properties--have been associated with postmenopausal breast cancer risk, but data are limited regarding their effect on survival. Dietary lignans are metabolized to enterolignans, which are subsequently absorbed and become bioavailable.",
keywords = "Humans, Aged, Female, Middle Aged, Prognosis, Case-Control Studies, Breast Neoplasms/*blood/pathology, 4-Butyrolactone/*analogs & derivatives/blood, Lignans/*blood, Postmenopause/blood, Tumor Markers, Biological/blood, Humans, Aged, Female, Middle Aged, Prognosis, Case-Control Studies, Breast Neoplasms/*blood/pathology, 4-Butyrolactone/*analogs & derivatives/blood, Lignans/*blood, Postmenopause/blood, Tumor Markers, Biological/blood",
author = "Katharina Buck and Alina Vrieling and Zaineddin, {Aida Karina} and Susen Becker and Anika H{\"u}sing and Rudolf Kaaks and Jakob Linseisen and Dieter Flesch-Janys and Jenny Chang-Claude",
year = "2011",
language = "English",
volume = "29",
pages = "3730--3738",
journal = "J CLIN ONCOL",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "28",

}

RIS

TY - JOUR

T1 - Serum enterolactone and prognosis of postmenopausal breast cancer.

AU - Buck, Katharina

AU - Vrieling, Alina

AU - Zaineddin, Aida Karina

AU - Becker, Susen

AU - Hüsing, Anika

AU - Kaaks, Rudolf

AU - Linseisen, Jakob

AU - Flesch-Janys, Dieter

AU - Chang-Claude, Jenny

PY - 2011

Y1 - 2011

N2 - Lignans--plant-derived compounds with estrogen-dependent and -independent anticarcinogenic properties--have been associated with postmenopausal breast cancer risk, but data are limited regarding their effect on survival. Dietary lignans are metabolized to enterolignans, which are subsequently absorbed and become bioavailable.

AB - Lignans--plant-derived compounds with estrogen-dependent and -independent anticarcinogenic properties--have been associated with postmenopausal breast cancer risk, but data are limited regarding their effect on survival. Dietary lignans are metabolized to enterolignans, which are subsequently absorbed and become bioavailable.

KW - Humans

KW - Aged

KW - Female

KW - Middle Aged

KW - Prognosis

KW - Case-Control Studies

KW - Breast Neoplasms/blood/pathology

KW - 4-Butyrolactone/analogs & derivatives/blood

KW - Lignans/blood

KW - Postmenopause/blood

KW - Tumor Markers, Biological/blood

KW - Humans

KW - Aged

KW - Female

KW - Middle Aged

KW - Prognosis

KW - Case-Control Studies

KW - Breast Neoplasms/blood/pathology

KW - 4-Butyrolactone/analogs & derivatives/blood

KW - Lignans/blood

KW - Postmenopause/blood

KW - Tumor Markers, Biological/blood

M3 - SCORING: Journal article

VL - 29

SP - 3730

EP - 3738

JO - J CLIN ONCOL

JF - J CLIN ONCOL

SN - 0732-183X

IS - 28

M1 - 28

ER -